SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

FDA approves Genentech's Tecentriq

Genentech said the FDA approved Tecentriq, with safety information in the release noting possible fertility problems in females. The notice also referenced Tecentriq Hybreza and pointed readers to prescribing information and medication guides.